Stock Analysis on Net
Stock Analysis on Net
Microsoft Excel LibreOffice Calc

Illumina Inc. (NASDAQ:ILMN)

Paying users zone. Data is hidden behind: .

  • Get 1-month access to Illumina Inc. for $15.99, or

  • get full access to the entire website for at least 3 months from $49.99.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Verified by Visa MasterCard SecureCode American Express SafeKey
Unlock

This is a one-time payment. There is no automatic renewal.

Illumina Inc. pages available today for free:

Analysis of Profitability Ratios
Quarterly Data

Beginner level

Profitability ratios measure the company’s ability to generate profitable sales from its resources (assets).

Profitability Ratios (Summary)

Illumina Inc., profitability ratios (quarterly data)

Microsoft Excel LibreOffice Calc
Apr 4, 2021 Dec 31, 2020 Sep 27, 2020 Jun 28, 2020 Mar 29, 2020 Dec 29, 2019 Sep 29, 2019 Jun 30, 2019 Mar 31, 2019 Dec 30, 2018 Sep 30, 2018 Jul 1, 2018 Apr 1, 2018 Dec 31, 2017 Oct 1, 2017 Jul 2, 2017 Apr 2, 2017 Dec 31, 2016 Oct 2, 2016 Jul 3, 2016 Apr 3, 2016
Return on Sales
Gross profit margin
Operating profit margin
Net profit margin
Return on Investment
Return on equity (ROE)
Return on assets (ROA)

Based on: 10-Q (filing date: 2021-04-28), 10-K (filing date: 2021-02-17), 10-Q (filing date: 2020-10-30), 10-Q (filing date: 2020-08-07), 10-Q (filing date: 2020-05-01), 10-K (filing date: 2020-02-11), 10-Q (filing date: 2019-10-25), 10-Q (filing date: 2019-07-31), 10-Q (filing date: 2019-04-26), 10-K (filing date: 2019-02-12), 10-Q (filing date: 2018-10-24), 10-Q (filing date: 2018-07-31), 10-Q (filing date: 2018-04-25), 10-K (filing date: 2018-02-13), 10-Q (filing date: 2017-10-25), 10-Q (filing date: 2017-08-03), 10-Q (filing date: 2017-05-05), 10-K (filing date: 2017-02-14), 10-Q (filing date: 2016-11-08), 10-Q (filing date: 2016-08-02), 10-Q (filing date: 2016-05-09).

Profitability ratio Description The company
Gross profit margin Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. Illumina Inc.’s gross profit margin ratio deteriorated from Q3 2020 to Q4 2020 and from Q4 2020 to Q1 2021.
Operating profit margin A profitability ratio calculated as operating income divided by revenue. Illumina Inc.’s operating profit margin ratio deteriorated from Q3 2020 to Q4 2020 and from Q4 2020 to Q1 2021.
Net profit margin An indicator of profitability, calculated as net income divided by revenue. Illumina Inc.’s net profit margin ratio improved from Q3 2020 to Q4 2020 but then deteriorated significantly from Q4 2020 to Q1 2021.
Profitability ratio Description The company
ROE A profitability ratio calculated as net income divided by shareholders’ equity. Illumina Inc.’s ROE improved from Q3 2020 to Q4 2020 but then deteriorated significantly from Q4 2020 to Q1 2021.
ROA A profitability ratio calculated as net income divided by total assets. Illumina Inc.’s ROA improved from Q3 2020 to Q4 2020 but then deteriorated significantly from Q4 2020 to Q1 2021.

Gross Profit Margin

Illumina Inc., gross profit margin calculation (quarterly data)

Microsoft Excel LibreOffice Calc
Apr 4, 2021 Dec 31, 2020 Sep 27, 2020 Jun 28, 2020 Mar 29, 2020 Dec 29, 2019 Sep 29, 2019 Jun 30, 2019 Mar 31, 2019 Dec 30, 2018 Sep 30, 2018 Jul 1, 2018 Apr 1, 2018 Dec 31, 2017 Oct 1, 2017 Jul 2, 2017 Apr 2, 2017 Dec 31, 2016 Oct 2, 2016 Jul 3, 2016 Apr 3, 2016
Selected Financial Data (US$ in millions)
Gross profit
Revenue
Profitability Ratio
Gross profit margin1
Benchmarks
Gross Profit Margin, Competitors2
AbbVie Inc.
Amgen Inc.
Eli Lilly & Co.
Gilead Sciences Inc.
Johnson & Johnson
Merck & Co. Inc.
Pfizer Inc.
Regeneron Pharmaceuticals Inc.
Thermo Fisher Scientific Inc.
Zoetis Inc.

Based on: 10-Q (filing date: 2021-04-28), 10-K (filing date: 2021-02-17), 10-Q (filing date: 2020-10-30), 10-Q (filing date: 2020-08-07), 10-Q (filing date: 2020-05-01), 10-K (filing date: 2020-02-11), 10-Q (filing date: 2019-10-25), 10-Q (filing date: 2019-07-31), 10-Q (filing date: 2019-04-26), 10-K (filing date: 2019-02-12), 10-Q (filing date: 2018-10-24), 10-Q (filing date: 2018-07-31), 10-Q (filing date: 2018-04-25), 10-K (filing date: 2018-02-13), 10-Q (filing date: 2017-10-25), 10-Q (filing date: 2017-08-03), 10-Q (filing date: 2017-05-05), 10-K (filing date: 2017-02-14), 10-Q (filing date: 2016-11-08), 10-Q (filing date: 2016-08-02), 10-Q (filing date: 2016-05-09).

1 Q1 2021 Calculation
Gross profit margin = 100 × (Gross profitQ1 2021 + Gross profitQ4 2020 + Gross profitQ3 2020 + Gross profitQ2 2020) ÷ (RevenueQ1 2021 + RevenueQ4 2020 + RevenueQ3 2020 + RevenueQ2 2020)
= 100 × ( + + + ) ÷ ( + + + ) =

2 Click competitor name to see calculations.

Profitability ratio Description The company
Gross profit margin Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. Illumina Inc.’s gross profit margin ratio deteriorated from Q3 2020 to Q4 2020 and from Q4 2020 to Q1 2021.

Operating Profit Margin

Illumina Inc., operating profit margin calculation (quarterly data)

Microsoft Excel LibreOffice Calc
Apr 4, 2021 Dec 31, 2020 Sep 27, 2020 Jun 28, 2020 Mar 29, 2020 Dec 29, 2019 Sep 29, 2019 Jun 30, 2019 Mar 31, 2019 Dec 30, 2018 Sep 30, 2018 Jul 1, 2018 Apr 1, 2018 Dec 31, 2017 Oct 1, 2017 Jul 2, 2017 Apr 2, 2017 Dec 31, 2016 Oct 2, 2016 Jul 3, 2016 Apr 3, 2016
Selected Financial Data (US$ in millions)
Income from operations
Revenue
Profitability Ratio
Operating profit margin1
Benchmarks
Operating Profit Margin, Competitors2
AbbVie Inc.
Amgen Inc.
Eli Lilly & Co.
Gilead Sciences Inc.
Johnson & Johnson
Merck & Co. Inc.
Pfizer Inc.
Regeneron Pharmaceuticals Inc.
Thermo Fisher Scientific Inc.
Zoetis Inc.

Based on: 10-Q (filing date: 2021-04-28), 10-K (filing date: 2021-02-17), 10-Q (filing date: 2020-10-30), 10-Q (filing date: 2020-08-07), 10-Q (filing date: 2020-05-01), 10-K (filing date: 2020-02-11), 10-Q (filing date: 2019-10-25), 10-Q (filing date: 2019-07-31), 10-Q (filing date: 2019-04-26), 10-K (filing date: 2019-02-12), 10-Q (filing date: 2018-10-24), 10-Q (filing date: 2018-07-31), 10-Q (filing date: 2018-04-25), 10-K (filing date: 2018-02-13), 10-Q (filing date: 2017-10-25), 10-Q (filing date: 2017-08-03), 10-Q (filing date: 2017-05-05), 10-K (filing date: 2017-02-14), 10-Q (filing date: 2016-11-08), 10-Q (filing date: 2016-08-02), 10-Q (filing date: 2016-05-09).

1 Q1 2021 Calculation
Operating profit margin = 100 × (Income from operationsQ1 2021 + Income from operationsQ4 2020 + Income from operationsQ3 2020 + Income from operationsQ2 2020) ÷ (RevenueQ1 2021 + RevenueQ4 2020 + RevenueQ3 2020 + RevenueQ2 2020)
= 100 × ( + + + ) ÷ ( + + + ) =

2 Click competitor name to see calculations.

Profitability ratio Description The company
Operating profit margin A profitability ratio calculated as operating income divided by revenue. Illumina Inc.’s operating profit margin ratio deteriorated from Q3 2020 to Q4 2020 and from Q4 2020 to Q1 2021.

Net Profit Margin

Illumina Inc., net profit margin calculation (quarterly data)

Microsoft Excel LibreOffice Calc
Apr 4, 2021 Dec 31, 2020 Sep 27, 2020 Jun 28, 2020 Mar 29, 2020 Dec 29, 2019 Sep 29, 2019 Jun 30, 2019 Mar 31, 2019 Dec 30, 2018 Sep 30, 2018 Jul 1, 2018 Apr 1, 2018 Dec 31, 2017 Oct 1, 2017 Jul 2, 2017 Apr 2, 2017 Dec 31, 2016 Oct 2, 2016 Jul 3, 2016 Apr 3, 2016
Selected Financial Data (US$ in millions)
Net income attributable to Illumina stockholders
Revenue
Profitability Ratio
Net profit margin1
Benchmarks
Net Profit Margin, Competitors2
AbbVie Inc.
Amgen Inc.
Eli Lilly & Co.
Gilead Sciences Inc.
Johnson & Johnson
Merck & Co. Inc.
Pfizer Inc.
Regeneron Pharmaceuticals Inc.
Thermo Fisher Scientific Inc.
Zoetis Inc.

Based on: 10-Q (filing date: 2021-04-28), 10-K (filing date: 2021-02-17), 10-Q (filing date: 2020-10-30), 10-Q (filing date: 2020-08-07), 10-Q (filing date: 2020-05-01), 10-K (filing date: 2020-02-11), 10-Q (filing date: 2019-10-25), 10-Q (filing date: 2019-07-31), 10-Q (filing date: 2019-04-26), 10-K (filing date: 2019-02-12), 10-Q (filing date: 2018-10-24), 10-Q (filing date: 2018-07-31), 10-Q (filing date: 2018-04-25), 10-K (filing date: 2018-02-13), 10-Q (filing date: 2017-10-25), 10-Q (filing date: 2017-08-03), 10-Q (filing date: 2017-05-05), 10-K (filing date: 2017-02-14), 10-Q (filing date: 2016-11-08), 10-Q (filing date: 2016-08-02), 10-Q (filing date: 2016-05-09).

1 Q1 2021 Calculation
Net profit margin = 100 × (Net income attributable to Illumina stockholdersQ1 2021 + Net income attributable to Illumina stockholdersQ4 2020 + Net income attributable to Illumina stockholdersQ3 2020 + Net income attributable to Illumina stockholdersQ2 2020) ÷ (RevenueQ1 2021 + RevenueQ4 2020 + RevenueQ3 2020 + RevenueQ2 2020)
= 100 × ( + + + ) ÷ ( + + + ) =

2 Click competitor name to see calculations.

Profitability ratio Description The company
Net profit margin An indicator of profitability, calculated as net income divided by revenue. Illumina Inc.’s net profit margin ratio improved from Q3 2020 to Q4 2020 but then deteriorated significantly from Q4 2020 to Q1 2021.

Return on Equity (ROE)

Illumina Inc., ROE calculation (quarterly data)

Microsoft Excel LibreOffice Calc
Apr 4, 2021 Dec 31, 2020 Sep 27, 2020 Jun 28, 2020 Mar 29, 2020 Dec 29, 2019 Sep 29, 2019 Jun 30, 2019 Mar 31, 2019 Dec 30, 2018 Sep 30, 2018 Jul 1, 2018 Apr 1, 2018 Dec 31, 2017 Oct 1, 2017 Jul 2, 2017 Apr 2, 2017 Dec 31, 2016 Oct 2, 2016 Jul 3, 2016 Apr 3, 2016
Selected Financial Data (US$ in millions)
Net income attributable to Illumina stockholders
Total Illumina stockholders’ equity
Profitability Ratio
ROE1
Benchmarks
ROE, Competitors2
AbbVie Inc.
Amgen Inc.
Eli Lilly & Co.
Gilead Sciences Inc.
Johnson & Johnson
Merck & Co. Inc.
Pfizer Inc.
Regeneron Pharmaceuticals Inc.
Thermo Fisher Scientific Inc.
Zoetis Inc.

Based on: 10-Q (filing date: 2021-04-28), 10-K (filing date: 2021-02-17), 10-Q (filing date: 2020-10-30), 10-Q (filing date: 2020-08-07), 10-Q (filing date: 2020-05-01), 10-K (filing date: 2020-02-11), 10-Q (filing date: 2019-10-25), 10-Q (filing date: 2019-07-31), 10-Q (filing date: 2019-04-26), 10-K (filing date: 2019-02-12), 10-Q (filing date: 2018-10-24), 10-Q (filing date: 2018-07-31), 10-Q (filing date: 2018-04-25), 10-K (filing date: 2018-02-13), 10-Q (filing date: 2017-10-25), 10-Q (filing date: 2017-08-03), 10-Q (filing date: 2017-05-05), 10-K (filing date: 2017-02-14), 10-Q (filing date: 2016-11-08), 10-Q (filing date: 2016-08-02), 10-Q (filing date: 2016-05-09).

1 Q1 2021 Calculation
ROE = 100 × (Net income attributable to Illumina stockholdersQ1 2021 + Net income attributable to Illumina stockholdersQ4 2020 + Net income attributable to Illumina stockholdersQ3 2020 + Net income attributable to Illumina stockholdersQ2 2020) ÷ Total Illumina stockholders’ equity
= 100 × ( + + + ) ÷ =

2 Click competitor name to see calculations.

Profitability ratio Description The company
ROE A profitability ratio calculated as net income divided by shareholders’ equity. Illumina Inc.’s ROE improved from Q3 2020 to Q4 2020 but then deteriorated significantly from Q4 2020 to Q1 2021.

Return on Assets (ROA)

Illumina Inc., ROA calculation (quarterly data)

Microsoft Excel LibreOffice Calc
Apr 4, 2021 Dec 31, 2020 Sep 27, 2020 Jun 28, 2020 Mar 29, 2020 Dec 29, 2019 Sep 29, 2019 Jun 30, 2019 Mar 31, 2019 Dec 30, 2018 Sep 30, 2018 Jul 1, 2018 Apr 1, 2018 Dec 31, 2017 Oct 1, 2017 Jul 2, 2017 Apr 2, 2017 Dec 31, 2016 Oct 2, 2016 Jul 3, 2016 Apr 3, 2016
Selected Financial Data (US$ in millions)
Net income attributable to Illumina stockholders
Total assets
Profitability Ratio
ROA1
Benchmarks
ROA, Competitors2
AbbVie Inc.
Amgen Inc.
Eli Lilly & Co.
Gilead Sciences Inc.
Johnson & Johnson
Merck & Co. Inc.
Pfizer Inc.
Regeneron Pharmaceuticals Inc.
Thermo Fisher Scientific Inc.
Zoetis Inc.

Based on: 10-Q (filing date: 2021-04-28), 10-K (filing date: 2021-02-17), 10-Q (filing date: 2020-10-30), 10-Q (filing date: 2020-08-07), 10-Q (filing date: 2020-05-01), 10-K (filing date: 2020-02-11), 10-Q (filing date: 2019-10-25), 10-Q (filing date: 2019-07-31), 10-Q (filing date: 2019-04-26), 10-K (filing date: 2019-02-12), 10-Q (filing date: 2018-10-24), 10-Q (filing date: 2018-07-31), 10-Q (filing date: 2018-04-25), 10-K (filing date: 2018-02-13), 10-Q (filing date: 2017-10-25), 10-Q (filing date: 2017-08-03), 10-Q (filing date: 2017-05-05), 10-K (filing date: 2017-02-14), 10-Q (filing date: 2016-11-08), 10-Q (filing date: 2016-08-02), 10-Q (filing date: 2016-05-09).

1 Q1 2021 Calculation
ROA = 100 × (Net income attributable to Illumina stockholdersQ1 2021 + Net income attributable to Illumina stockholdersQ4 2020 + Net income attributable to Illumina stockholdersQ3 2020 + Net income attributable to Illumina stockholdersQ2 2020) ÷ Total assets
= 100 × ( + + + ) ÷ =

2 Click competitor name to see calculations.

Profitability ratio Description The company
ROA A profitability ratio calculated as net income divided by total assets. Illumina Inc.’s ROA improved from Q3 2020 to Q4 2020 but then deteriorated significantly from Q4 2020 to Q1 2021.